Alzai Health Corp.
Toronto Stock Exchange VenturesTotal Valuation
Alzai Health Corp. carries a market capitalization of 23.73M, placing it among publicly traded companies globally. Its enterprise value stands at 565,815.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.73M |
| Enterprise Value | 565,815.00 |
Share Statistics
Alzai Health Corp. currently has 53.28M shares outstanding.
| Shares Outstanding | 53.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 20.93 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Alzai Health Corp. maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.14, indicating conservative leverage, while an interest coverage ratio of -105.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.33 |
| Quick Ratio | 0.30 |
| Debt / Equity | -63.14 |
| Debt / EBITDA | -0.23 |
| Interest Coverage | -105.93 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2,063.13 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Alzai Health Corp.'s stock has declined approximately -11.90476% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 0.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.90476% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.40 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Alzai Health Corp. generated 27,039.00 in revenue and converted that into -3.68M in net income, yielding earnings per share of -0.06. EBITDA reached -3.61M, while operating income came in at -3.62M.
| Revenue | 27,039.00 |
| Gross Profit | N/A |
| Operating Income | -3.62M |
| Pretax Income | -3.68M |
| Net Income | -3.68M |
| EBITDA | -3.61M |
| EBIT | -3.62M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
Alzai Health Corp. holds 268,074.00 in cash and equivalents against 833,889.00 in total debt, resulting in a net debt position of 565,815.00. Total book value stands at -1.32M, with working capital of -870,610.00 providing operational flexibility.
| Cash & Cash Equivalents | 268,074.00 |
| Total Debt | 833,889.00 |
| Net Debt | 565,815.00 |
| Equity (Book Value) | -1.32M |
| Book Value Per Share | -0.02 |
| Working Capital | -870,610.00 |
Cash Flow
Alzai Health Corp. produced -2.59M in operating cash flow over the past twelve months. After subtracting -19,405.00 in capital expenditures, free cash flow totaled -2.61M - equivalent to -0.04 per share.
| Operating Cash Flow | -2.59M |
| Capital Expenditures | -19,405.00 |
| Free Cash Flow | -2.61M |
| FCF Per Share | -0.04 |
Margins
Alzai Health Corp. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -13,405.82 and net profit margin of -13,593.12 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -13,405.82 |
| Pretax Margin | -13,593.12 |
| Profit Margin | -13,593.12 |
| EBITDA Margin | -13,345.08 |
Scores
Alzai Health Corp. posts an Altman Z-Score of -43.85, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -43.85 |